|
0
|
|
Multicentre gene therapy for OTOF-related deafness followed up to 2.5 years.
(nature.com)
|
Jiang L
…
Shu Y
Nature
2026-05-01
|
#clinical trial
#gene therapy
#aav
#hearing
#deafness
|
|
0
|
|
Clinical application of base editing for treating beta-thalassaemia.
(nature.com)
|
Lai Y
…
Chen J
Nature
2026-05-01
|
#clinical trial
#gene therapy
#thalassaemia
#stem cell
|
|
0
|
|
Intravitreal photoswitch therapy in advanced retinitis pigmentosa: a phase 1 open-label trial.
(nature.com)
|
Casson RJ
…
Van Gelder RN
Nature Medicine
2026-05-01
|
#clinical trial
#neuroprotection
#retinopathy
#phototherapy
#ophthalmology
|
|
0
|
|
The NPR1 agonist antibody XXB750 in heart failure: a phase 2 randomized trial.
(nature.com)
|
Solomon SD
…
Lefkowitz MP
Nature Medicine
2026-05-01
|
#clinical trial
#immunotherapy
#biomarker
#heart failure
|
|
0
|
|
Prospective evaluation of genomics-guided off-label treatment.
(nature.com)
|
Verkerk K
…
Voest EE
Nature
2026-05-01
|
#genomics
#cancer
#clinical trial
#therapeutics
#precision medicine
|
|
0
|
|
Integrase versus protease inhibitor therapy in advanced HIV disease (LAPTOP): a multicountry, randomised, open-label, non-inferiority trial.
(linkinghub.elsevier.com)
|
Behrens GMN
…
Pozniak A
Lancet Infectious Diseases
2026-05-01
|
#clinical trial
#hiv
#therapy
|
|
0
|
|
Safety and efficacy of CRS3123 in adults with a primary episode or first recurrence of Clostridioides difficile infection: a phase 2, randomised, double-blind, multicentre, vancomycin-controlled study.
(linkinghub.elsevier.com)
|
Louie T
…
Bruss JB
Lancet Infectious Diseases
2026-05-01
|
#infection
#clinical trial
#antibiotic
#recurrence
|
|
0
|
|
The effectiveness of long-lasting spatial repellent emanators against malaria in humanitarian crisis settings in northern Nigeria: a two-arm pragmatic, open-label, controlled trial.
(linkinghub.elsevier.com)
|
Allan RJ
…
Messenger LA
Lancet Infectious Diseases
2026-05-01
|
#infection
#malaria
#clinical trial
#vector control
#displacement
|
|
0
|
|
Elraglusib and chemotherapy in metastatic pancreatic ductal adenocarcinoma: a randomized controlled phase 2 trial.
(nature.com)
|
Mahalingam D
…
Bekaii-Saab TS
Nature Medicine
2026-05-01
|
#cancer
#clinical trial
#immunotherapy
#chemotherapy
#pancreatic
|